In this article
A recent study published in the European Journal of Clinical Nutrition suggests that diet may play a meaningful role in preventing pancreatic cancer. The study examined the relationship between pancreatic cancer risk and the intake of nutrients involved in methyl metabolism — a biological process critical to DNA synthesis and gene regulation.
Dr. Zhang Jianjun, associate professor of epidemiology at the Indiana University Fairbanks School of Public Health and senior author of the study, explained that methylation is closely linked to tumor formation and growth. Key nutrients that support methyl metabolism include folic acid, vitamins B6 and B12, and methionine. The study found that participants with the highest folic acid intake had a 69% lower risk of pancreatic cancer compared to those with the lowest intake. While vitamin B6 alone did not show a statistically significant effect, combining high intakes of both folic acid and vitamin B6 reduced pancreatic cancer risk by 76% — a finding with significant practical implications for dietary guidance.
While these findings are promising, the American Cancer Institute (AICR) advises against relying on supplements to prevent cancer, recommending instead that people obtain these nutrients through whole foods as part of a balanced, cancer-protective diet. Fortunately, both folic acid and vitamin B6 are found in a wide variety of commonly available foods.
Folic acid is abundant in green leafy vegetables, beans, nuts, and fruits. Vitamin B6 can be found in fortified grains, beans, poultry, fish, and a range of vegetables and fruits — particularly dark green leafy vegetables, papaya, oranges, and cantaloupe. Building meals around these foods is a practical, accessible step that may offer meaningful protection against pancreatic cancer while supporting overall health.
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination — travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Medical Disclaimer
This article is for educational purposes only and should not replace medical advice, diagnosis, or treatment from a qualified oncology specialist. Every patient's case is different. Treatment decisions should always be made after a review of complete medical records by the treating medical team.
Treatment availability, eligibility, timelines, and access can change. Any clinical trial participation depends on detailed review and approval by the trial hospital or investigator.